Observational studyEuropean journal of clinical investigation2026
Early Hemolysis, Myolysis and Renal Stress Following Pentaspline Pulsed Field Versus Radiofrequency Ablation of Atrial Fibrillation.
Observational study in European journal of clinical investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundPulsed field ablation (PFA) is an effective alternative to radiofrequency ablation (RFA) for pulmonary vein isolation (PVI) in atrial fibrillation (AF), offering procedural advantages and a favourable safety profile. However, single-shot PFA (ssPFA) has been associated with biochemical evidence of haemolysis and myocardial injury, raising concerns regarding potential renal impairment.
methodsIn this prospective observational study, 40 patients undergoing first-time PVI were analysed (20 RFA and 20 pentaspline ssPFA). Blood samples were obtained pre-procedure and 1, 4 and 24 h post-ablation. Markers of myolysis (myoglobin), haemolysis (haptoglobin and bilirubin), renal function (creatinine, eGFR and Cystatin C) and tubular stress (NGAL and KIM-1) were assessed. Biomarker trajectories were analysed using two-way repeated-measures ANOVA and correlation analyses were performed.
resultsSignificantly higher postprocedural myoglobin levels, greater reductions in haptoglobin and greater elevations in bilirubin were observed after ssPFA than after RFA (all interaction effects p < 0.001). Changes in renal function and tubular stress biomarkers were modest and largely comparable between modalities. Exploratory correlation analyses demonstrated inverse associations between changes in myoglobin and eGFR, with the strongest correlation observed at 24 h (ρ = -0.55). The association between early myoglobin release and subsequent eGFR changes was confined to the ssPFA cohort.
conclusionsssPFA induces substantially greater acute myolysis and haemolysis than RFA following PVI. No patient met serum creatinine-defined criteria of acute kidney injury within the observation period. Myoglobin release was associated with transient renal functional changes and may represent a mechanistically plausible, non-causal marker of early renal stress following ssPFA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.